Creatinin


Also found in: Medical, Encyclopedia, Wikipedia.
Related to Creatinin: creatine, bun

Cre`at´i`nin


n.1.(Physiol. Chem.) A white, crystalline, nitrogenous body closely related to creatin but more basic in its properties, formed from the latter by the action of acids, and occurring naturally in muscle tissue and in urine.
Mentioned in ?
References in periodicals archive ?
Serum electrolytes, thyroid and parathyroid hormones, and renal function tests (albumin, creatinin, and urea) were within normal limits.
For this purpose leukocyte (WBC), hemoglobin (HGB), haematocrit (HCT), thrombocyte (PLT), alanine aminotransferase (ALT), aspartate aminotransferase (AST), creatinin (CR), As and Hg levels were investigated in workers (n=99) and their controls (n=81).
Laboratory analysis revealed as a serum creatinin 0.9 mg/dl, hemoglobin 14.9 g/dl, glucose 486 mg/dL, CRP 156 mg/L, WBC14.5x106 cells/mL, sodium 132 was detected in his physical examination (Fig.1).
Clinical characteristics of patients with lipodystrophies Generalized All subjects lipodystrophy (n=32 ) (n=13) Age (years) 30 (21-38) 21 (15-30) Gender (F/M) 24/8 9/4 Glucose (mg/dL) 143 (114-202) 144 (108-224) HbA1c (%) 8.2 (6.2-9.5) 7.0 (6.0-10.7) Triglyceride (mg/dL) 372 (223-659) 581 (310-1268) Total cholesterol (mg/dL) 181 (159-235) 169 (145-257) LDL cholesterol (mg/dL) 98 (68.2-117) 91 (60-107) HDL cholesterol (mg/dL) 28 (22-37) 27 (19-31) Creatinin (mg/dL) 0.6 (0.5-0.9) 0.5 (0.4-0.7) ALT (IU/L) 24 (18-44) 29 (18-52) Leptin (ng/mL) 1.2 (0.4-4.5) 0.3 (0.1-0.7) Adiponectin ([micro]g/mL) 2.7 (0.9-5.3) 0.7 (0.5-3.8) Partial P lipodystrophy (generalized vs.
No significant differences were observed among the different groups in cholesterol, triglycerides, urea, creatinin, ALT and AST.
Laboratory tests revealed high serum urea and creatinin levels (100 mg/dl, 1.9 mg/dl respectively), normal troponin I and CK-MB, and high N-terminal pro-brain natriuretic peptide levels, 22 012 pg/ml.
Examenes complementarios: creatinin quinasa (CK) total: 2.404UI/L (VN: 30-223UI/L), CK Post ejercicio: 2.869UI/L (VN: 30-223UI/L), radiografia de columna dorsolumbar anteroposterior y lateral donde se evidencia inclinacion lateral izquierda del eje de la columna.
B1 (ug/day) 0.21 0.09 0.19 0.05 Follic acid (ug/day) 77 20 94 12 Carotene (ug/day) 1072 551 1451 293 Ca (mg/day) 96 50 105 38 P (mg/day) 227 39 265 14 Biochem data TP (g/dl) 7.1 0.3 7.5 0.3 Alb (g/dl) 4.3 0.2 4.4 0.0 BUN (mg/dl) 17.7 8.7 24.7 1.1 Creatinin (mg/dl) 3.0 3.0 8.7 0.7 Family Dietitian mean sd mean sd Nutrient intake Body weight (kg) 48.8 3.8 50.1 3.4 Energy (kcal/kg) 33.1 4.5 32.8 6.9 Protein (g/kg) 1.17 0.26 1.25 0.28 Salt (g/day) 2.9 0.8 4.3 1.5 Vit.
La elevacion de biomarcadores, es significativa en los pacientes con DENV, especialmente los marcadores de dano miocardico que estan presentes en cerca del 25% de los pacientes, ejemplo de ellos son la mioglobina, creatinin quinasa fraccion MB (CK-MB), y troponina T Otros con menor especificidad que tambien se pueden elevar son el fragmento N terminal del peptido natriuretico tipo B (NT-proBNP), los acidos grasos de union a proteinas de tipo cardiaco (h-FABP).
We therefore considered the following confounders to be adjusted for in the analysis: logistic EuroSCORE, sex, age, hypertension, diabetes mellitus, unstable angina pectoris, previous myocardial infarction, previous percutaneous transluminal coronary angioplasty, previous cardiac surgery, preoperative creatinin, left ventricular ejection fraction (LVEF; <30%, 30-50%, and >50%), type ofsurgery (isolated coronary artery bypass grafting [CABG], isolated valve, CABG + valve, and others), and emergency indication.
BNP (pg/mL) Independent variables CRP (mg/L) Creatinin Na (mg/dL) (mmol/L) 2.44 0.84 -0.81 p value 0.017 0.40 0.42 Constant value Regression coefficient 1652.06 SE regression coefficient 676.00 BNP (pg/mL) Independent variables K sRAGE Model (mmol/L) (pg/mL) [R.sup.2] 1.40 2.72 0.20 p value 0.17 0.008 Constant value Regression coefficient 2.49 SE regression coefficient 0.92 CRP: C-reactive protein; sRAGE: soluble receptor of advanced glycation end products; SE: standard error.

Full browser ?